Get started
Author

Remei Blanco

Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)
2005 · Javier Martín, Andrés Poveda, et al. · Journal of Clinical Oncology · 353
PDF
Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
2009 · Rafael Rosell, Laia Perez-Roca, et al. · PLoS ONE · 164
PDF
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions
2019 · Sergio Villatoro, Clara Mayo‐de‐las‐Casas, et al. · Molecular Oncology · 90
PDF
Anticachectic Efficacy of Megestrol Acetate at Different Doses and Versus Placebo in Patients With Neoplastic Cachexia
1998 · Catalina Vadell, Miguel Angel Seguí, et al. · American Journal of Clinical Oncology · 61
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial
2022 · Mariano Provencio, Ana Laura Ortega, et al. · JAMA Oncology · 55
PDF
Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients
2019 · Ivana Sullivan, Pau Riera, et al. · Angiogenesis · 47
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns
2019 · Sergi Clavé, Natalia Rodon, et al. · Clinical Lung Cancer · 37
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
2018 · David Carbone, Michael Sharpnack, et al. · Journal of Translational Medicine · 28
PDF
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation
2020 · Miguel Barquín, Virginia Calvo, et al. · Cancer Epidemiology · 26
Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status
2012 · Francesc Casas, Concha León, et al. · Clinical & Translational Oncology · 23
Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain
2017 · Maria-Jose Molina-Garrido, Carmen Guillén-Ponce, et al. · Journal of Geriatric Oncology · 20
Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study
2008 · Remei Blanco, Josep Solé, et al. · Lung Cancer · 19
Phase II study of durvalumab (MEDI4736) in cancer patients HIV-1-infected.
2019 · María González-Cao, Teresa Moran, et al. · Journal of Clinical Oncology · 17
Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes
2023 · Remei Blanco, Manuel Dómine, et al. · Lung Cancer · 15
PDF
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
2022 · Mariano Provencio, Manuel Cobo, et al. · BMC Cancer · 15
Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.
2017 · Niki Karachaliou, Guillermo Crespo, et al. · Journal of Clinical Oncology · 13
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
2021 · Lourdes Gutiérrez, Ana Royuela, et al. · BMC Cancer · 11
PDF
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma
2021 · Mariona Riudavets, Joaquim Bosch-Barrera, et al. · Clinical & Translational Oncology · 9
Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
2018 · Teresa Morán, Eudald Felip, et al. · Oncotarget · 9
PDF
Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma
2014 · Alfredo Sánchez Hernández, Oscar José Juan, et al. · Clinical & Translational Oncology · 9
Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer
2008 · Rafael Rosell, Christian Manegold, et al. · Clinical Lung Cancer · 8
Multidisciplinary treatment planning in elderly patients with cancer: a prospective observational study
2016 · Remei Blanco, Merce Capo, et al. · The Journal of Community and Supportive Oncology · 6
PDF
Lung Cancer OncoGuia
2009 · Lung Cancer OncoGuia Group, P. Manchon Walsh, et al. · Clinical & Translational Oncology · 6
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non–Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery
2016 · Mariacarmela Santarpia, Jose Luis Ramirez, et al. · Clinical Lung Cancer · 5
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain
2025 · Mariano Provencio, Manuel Cobo, et al. · The Lancet Regional Health - Europe · 4
Works count: 40
Citation count: 1,057
H-index: 15
I10-index: 17
Year
Topic
Type